• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于单叠氮碘化丙啶活菌PCR的快速分子表型抗菌药敏试验。

Rapid molecular phenotypic antimicrobial susceptibility test for based on propidium monoazide viability PCR.

作者信息

Tjandra Kristel C, Ram-Mohan Nikhil, Abe Ryuichiro, Wang Tza-Huei, Yang Samuel

机构信息

Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Departments of Mechanical Engineering and Biomedical Engineering, The Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

bioRxiv. 2023 Mar 1:2023.03.01.530513. doi: 10.1101/2023.03.01.530513.

DOI:10.1101/2023.03.01.530513
PMID:36909582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10002740/
Abstract

(NG) is an urgent threat to antimicrobial resistance (AMR) worldwide. NG has acquired rapid resistance to all previously recommended treatments leaving ceftriaxone monotherapy as the first and last line of therapy for uncomplicated NG. The ability to rapidly determine susceptibility, which is currently nonexistent for NG, has been proposed as a strategy to preserve ceftriaxone by using alternative treatments. Herein, we used a DNA-intercalating dye in combination with NG-specific primers/probes to generate qPCR cycle threshold (Ct) values at different concentrations of 2 NG-relevant antimicrobials. Our proof of concept dual-antimicrobial logistic regression model based on the differential Ct measurements achieved an AUC of 0.93 with a categorical agreement for susceptibility of 84.6%. When surveying the performance against each antimicrobial separately, the model predicted 90% and 75% susceptible and resistant strains respectively to ceftriaxone and 66.7% and 83.3% susceptible and resistant strains respectively to ciprofloxacin. We further validated the model against the individual replicates and determined the accuracy of the model in classifying susceptibility agnostic of the inoculum size. We demonstrated a novel PCR-based approach to determine phenotypic ciprofloxacin and ceftriaxone susceptibility information for NG with reasonable accuracy in under 30 min, a significant improvement compared to the conventional method which takes 3 days.

摘要

淋球菌(NG)对全球的抗菌药物耐药性(AMR)构成了紧迫威胁。NG已对所有先前推荐的治疗方法迅速产生耐药性,使得头孢曲松单药治疗成为无并发症NG感染的一线和最后一线治疗方法。目前不存在快速确定NG药敏性的方法,有人提出通过使用替代治疗方法来保留头孢曲松,以此作为一种策略。在此,我们使用一种DNA嵌入染料与NG特异性引物/探针相结合,在两种与NG相关的抗菌药物的不同浓度下生成定量聚合酶链反应(qPCR)循环阈值(Ct)值。我们基于差异Ct测量的概念验证双抗菌药物逻辑回归模型的曲线下面积(AUC)为0.93,药敏性分类一致性为84.6%。当分别检测针对每种抗菌药物的性能时,该模型对头孢曲松的敏感菌株和耐药菌株的预测分别为90%和75%,对环丙沙星的敏感菌株和耐药菌株的预测分别为66.7%和83.3%。我们进一步针对单个重复样本验证了该模型,并确定了该模型在不考虑接种量的情况下对药敏性进行分类的准确性。我们展示了一种基于PCR的新方法,可在30分钟内以合理的准确性确定NG对环丙沙星和头孢曲松的表型药敏性信息,与需要3天的传统方法相比有显著改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/ea3072a78111/nihpp-2023.03.01.530513v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/f7e778d73773/nihpp-2023.03.01.530513v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/6a3b5500a30e/nihpp-2023.03.01.530513v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/2f025d12df16/nihpp-2023.03.01.530513v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/0dcf6c532f99/nihpp-2023.03.01.530513v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/7db08163c7f7/nihpp-2023.03.01.530513v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/ea3072a78111/nihpp-2023.03.01.530513v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/f7e778d73773/nihpp-2023.03.01.530513v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/6a3b5500a30e/nihpp-2023.03.01.530513v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/2f025d12df16/nihpp-2023.03.01.530513v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/0dcf6c532f99/nihpp-2023.03.01.530513v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/7db08163c7f7/nihpp-2023.03.01.530513v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e336/10002740/ea3072a78111/nihpp-2023.03.01.530513v1-f0007.jpg

相似文献

1
Rapid molecular phenotypic antimicrobial susceptibility test for based on propidium monoazide viability PCR.基于单叠氮碘化丙啶活菌PCR的快速分子表型抗菌药敏试验。
bioRxiv. 2023 Mar 1:2023.03.01.530513. doi: 10.1101/2023.03.01.530513.
2
Rapid Molecular Phenotypic Antimicrobial Susceptibility Test for Based on Propidium Monoazide Viability PCR.基于单叠氮碘化丙啶活力PCR的快速分子表型抗菌药敏试验
ACS Infect Dis. 2023 May 12;9(5):1160-1167. doi: 10.1021/acsinfecdis.3c00096. Epub 2023 Apr 28.
3
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.2012 - 2014年期间巴基斯坦卡拉奇淋病奈瑟菌的抗菌药物耐药性及多重抗原序列分型(NG - MAST)基因型
BMC Infect Dis. 2016 Jul 22;16:353. doi: 10.1186/s12879-016-1673-1.
4
Antimicrobial Susceptibility Testing Patterns of from Patients Attending Sexually Transmitted Infections Clinics in Six Regions in Tanzania.坦桑尼亚六个地区性传播感染诊所患者的抗菌药物敏感性测试模式
Trop Med Infect Dis. 2022 Jun 2;7(6):89. doi: 10.3390/tropicalmed7060089.
5
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.泰国曼谷淋病奈瑟菌菌株的抗菌药敏性:1994 - 1995年
Sex Transm Dis. 1997 Mar;24(3):142-8. doi: 10.1097/00007435-199703000-00004.
6
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目,美国 27 个监测点,2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
7
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.2011 - 2012年南京性传播疾病门诊有症状男性淋病奈瑟菌分离株的抗菌药物敏感性:对头孢曲松敏感性降低的分离株的遗传特征
BMC Infect Dis. 2014 Nov 27;14:622. doi: 10.1186/s12879-014-0622-0.
8
Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis.淋病奈瑟菌的抗菌药物敏感性检测:一项基于人群的原理验证性回顾性分析。
Lancet Microbe. 2023 Jul;4(7):e544-e551. doi: 10.1016/S2666-5247(23)00071-X. Epub 2023 Jun 16.
9
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).俄罗斯耐多药淋病奈瑟菌的分子流行病学(现状,2015年)
BMC Infect Dis. 2016 Aug 9;16:389. doi: 10.1186/s12879-016-1688-7.
10
Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.淋病奈瑟菌的表型-分子药敏试验和冻干抗菌药物。
Diagn Microbiol Infect Dis. 2022 Feb;102(2):115590. doi: 10.1016/j.diagmicrobio.2021.115590. Epub 2021 Oct 29.

本文引用的文献

1
Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.美国淋病奈瑟菌的管理:从制定 2020 年淋病治疗推荐意见和 2021 年美国疾病控制与预防中心性传播感染治疗指南中获得的证据总结。
Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S95-S111. doi: 10.1093/cid/ciac043.
2
Characterization of a Neisseria gonorrhoeae Ciprofloxacin panel for an antimicrobial resistant Isolate Bank.淋病奈瑟菌环丙沙星药敏panel 的特征分析用于建立抗菌药物耐药分离株库。
PLoS One. 2022 Mar 10;17(3):e0264149. doi: 10.1371/journal.pone.0264149. eCollection 2022.
3
A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable Uropathogenic and .
一种新型基于吖啶橙单染色的 PCR 检测法可定量检测尿路致病性 和 。
Front Cell Infect Microbiol. 2022 Feb 1;12:794323. doi: 10.3389/fcimb.2022.794323. eCollection 2022.
4
Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.对头孢曲松敏感性降低的异性恋男性中耐多药淋病奈瑟菌感染,泰国首次报告。
Sci Rep. 2021 Nov 4;11(1):21659. doi: 10.1038/s41598-021-00675-y.
5
Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report.瑞士发现一株头孢曲松耐药淋病奈瑟菌的分子特征:病例报告。
Ann Clin Microbiol Antimicrob. 2021 Aug 6;20(1):52. doi: 10.1186/s12941-021-00456-5.
6
Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay.采用 SpeeDx ResistancePlus GC 检测淋病奈瑟菌环丙沙星耐药性的反射检测。
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.00089-21.
7
Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.更新至 2020 年美国 CDC 淋球菌感染治疗指南
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1911-1916. doi: 10.15585/mmwr.mm6950a6.
8
Men and Women Have Similar Neisseria gonorrhoeae Bacterial Loads: a Comparison of Three Anatomical Sites.男性和女性的淋病奈瑟菌细菌载量相似:三个解剖部位的比较
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01171-20.
9
The Laboratory Diagnosis of : Current Testing and Future Demands.《实验室诊断:当前检测与未来需求》
Pathogens. 2020 Jan 31;9(2):91. doi: 10.3390/pathogens9020091.
10
Epidemiology of gonorrhoea: a global perspective.淋病的流行病学:全球视角
Sex Health. 2019 Sep;16(5):401-411. doi: 10.1071/SH19061.